Response to Steiner and Bogerts on N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.
- 1 March 2015
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1) , 292-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorderSchizophrenia Research, 2014
- Prevalence ofN-Methyl-D-Aspartate Receptor Autoantibodies in the Peripheral BloodJAMA Psychiatry, 2014
- Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrityMolecular Psychiatry, 2013
- Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of SchizophreniaJAMA Psychiatry, 2013
- Association of cerebrospinal fluid anti–NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosusArthritis & Rheumatism, 2008
- Blood Test Detecting Autoantibodies to N-Methyl-d-aspartate Neuroreceptors for Evaluation of Patients with Transient Ischemic Attack and StrokeClinical Chemistry, 2003